<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-vaccines-07-00074">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bricault</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Yusim</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Seaman</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Yoon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Theiler</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Giorgi</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>Wagh</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Theiler</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hraber</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Macke</surname>
    <given-names>J.P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design</article-title>
  <source>Cell Host Microbe</source>
  <year>2019</year>
  <volume>25</volume>
  <fpage>59</fpage>
  <lpage>72</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chom.2018.12.001</pub-id>
  <pub-id pub-id-type="pmid">30629920</pub-id>
 </element-citation>
</ref>
